Arkolith/Insider Trading/CRDF/Form 4

Levine James E.

Chief Financial OfficerCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Sep 13, 2021
Net Buying
Open-Market Buys
$194K
Open-Market Sells
$0
Net Open-Market Flow
$194K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2021Buy(P)5K$6.62$33K5K
Sep 10, 2021Buy(P)5K$6.75$34K10K
Sep 10, 2021Buy(P)10K$6.38$64K20K
Sep 10, 2021Buy(P)5K$6.35$32K25K
Sep 10, 2021Buy(P)5K$6.32$32K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-21-018433) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML